| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $780.6M | +23.6% |
| Cost of Revenue | $317.3M | +24.9% |
| Gross Profit | $463.3M | +22.8% |
| R&D Expense | $0 | — |
| SG&A Expense | $284.8M | +35.4% |
| Operating Income | $179.6M | +5.7% |
| Pre-tax Income | $92.6M | -6.0% |
| Income Tax | $29.7M | +1.3% |
| Net Income | $62.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $231.3M | +227.7% |
| Short-term Investments | $155.4M | +68.6% |
| Accounts Receivable | $211.3M | -7.5% |
| Inventory | $40.9M | +15.1% |
| Current Assets | $691.4M | +43.4% |
| Total Assets | $1.66B | -0.4% |
| Current Liabilities | $440.0M | -13.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $329.3M | +60.7% |
| Capital Expenditures | $1.7M | +5.3% |
| Investing Cash Flow | -$63.5M | +77.9% |
| Financing Cash Flow | -$110.2M | -81.9% |
| Free Cash Flow | $327.6M | +61.1% |
| -9.1% |
| EPS (Basic) | $1.98 | -7.5% |
| EPS (Diluted) | $1.73 | -7.0% |
| Total Liabilities |
| $1.36B |
| -5.5% |
| Stockholders' Equity | $301.7M | +31.8% |